Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News BioRestorative Therapies Inc BRTX

BioRestorative Therapies, Inc. is engaged in developing therapeutic products and medical therapies using cell and tissue protocols, primarily involving adult stem cells. The Company has two core programs that relate to the treatment of disc/spine disease and metabolic disorders. Its lead cell therapy candidate, BRTX-100, is a product formulated from autologous (or a person's own) cultured... see more

Recent & Breaking News (NDAQ:BRTX)

BioRestorative Therapies Submits IND Application to FDA to Treat Patients with Degenerative Disc Disease

GlobeNewswire January 9, 2017

BioRestorative Therapies Announces Publication in Medical Journal of Positive Results of Long-Term Safety and Feasibility Study Using Cell Therapy to Treat Patients with Degenerative Disc Disease

GlobeNewswire September 12, 2016

BioRestorative Therapies Announces Presentation at 3rd Annual Regenerative Medicine Essentials Course

GlobeNewswire July 13, 2016

BioRestorative Therapies Announces Completion of Human Safety and Feasibility Study on the Use of Hypoxic Cultured Stem Cells to Treat Chronic Lower Back Pain

GlobeNewswire June 28, 2016

BioRestorative Therapies to Present at 5th Annual Marcum MicroCap Conference

GlobeNewswire May 31, 2016

BioRestorative Therapies Announces Promising Data to Advance its Program for the Treatment of Metabolic Disorders

GlobeNewswire May 23, 2016

BioRestorative Therapies Deepens Board of Directors With Addition of Robert B. Catell, Former Chairman and CEO of KeySpan Corporation and Chairman of National Grid, US

GlobeNewswire February 23, 2016

BioRestorative Therapies Names Lead Cell-Based Lumbar Disc Therapeutic Product

GlobeNewswire February 9, 2016

BioRestorative Therapies Provides Company Updates With Shareholder Letter

GlobeNewswire December 21, 2015

BioRestorative Therapies Appoints John M. Desmarais, J.D. to Its Board of Directors

GlobeNewswire December 2, 2015

BioRestorative Therapies Granted Key Metabolic Patent

GlobeNewswire November 19, 2015

BioRestorative Therapies Announces Patent Granted for Its Licensed Curved Needle Device

GlobeNewswire November 3, 2015

BioRestorative Therapies Announces Research Collaboration With University of Pennsylvania

GlobeNewswire September 15, 2015

BioRestorative Therapies to Evaluate Cell Delivery Technology to Advance Metabolic Program Towards Human Trials

GlobeNewswire July 20, 2015

BioRestorative Therapies to Evaluate Cell Delivery Technology to Advance Metabolic Program Towards Human Trials

GlobeNewswire July 20, 2015

BioRestorative Therapies, Inc. Announces Reverse Stock Split in Preparation for Planned Uplisting to NASDAQ Capital Market

GlobeNewswire July 6, 2015

BioRestorative Therapies Announces Conversion of $5.15 Million of Debt to Equity

GlobeNewswire June 2, 2015

BioRestorative Therapies to Present ThermoStem(R) Data at 21st Annual Meeting of the International Society for Cellular Therapy

GlobeNewswire May 27, 2015

BioRestorative Therapies to Present at the 2015 Marcum MicroCap Conference in New York City

GlobeNewswire May 26, 2015

BioRestorative Therapies, Inc. Announces Opening of New Headquarters and Laboratory Facility in New York

Business Wire April 14, 2015